However, after STZ treatment, the percentage of insulin-positive cells in both groups were similar (Figure 4D), suggesting that Glut4 activation in the muscle may have helped mitigate severe DM symptoms by enhancing glucose uptake and reducing hyperglycemia. The gene discussed is SLC2A4; the disease is Hyperglycemia.